Juvenile Scleroderma
- PMID: 37966656
- DOI: 10.1007/s12098-023-04894-1
Juvenile Scleroderma
Abstract
Localised scleroderma and systemic sclerosis are rare chronic fibrosing disorders seen in children, and are collectively referred to as Juvenile Scleroderma. Histopathology of the two forms is non-distinct but they differ in terms of vasculopathy, internal organ involvement, morbidity and mortality. Raynaud's phenomenon with digital tip ulcers is considered hallmark of systemic sclerosis. Quality of life gets greatly affected by these diseases. Early identification in the inflammatory phase of the disease, effective treatment and strict surveillance remain crucial for better outcomes. Emerging vascular and immunosuppressive strategies, coupled with efforts from scientific community to develop better biomarkers and monitoring tools, help constantly to improve survival rates.
Keywords: Digital ulcers; Juvenile scleroderma; Nail-fold capillaroscopy; Raynaud’s phenomenon; Systemic sclerosis.
© 2023. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.
References
-
- Torok KS, Stevens AM. Juvenile systemic sclerosis. In: Petty R, Laxer R, Lindsley C, et al., editors. Textbook of Pediatric Rheumatology. 8th ed. Elsevier; Philadelphia; 2021. p. 377–401.
-
- Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Related Disord. 2017;2:137–52. - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
